327 related articles for article (PubMed ID: 17553102)
1. Alpha-synuclein pathology in the olfactory pathways of dementia patients.
Hubbard PS; Esiri MM; Reading M; McShane R; Nagy Z
J Anat; 2007 Jul; 211(1):117-24. PubMed ID: 17553102
[TBL] [Abstract][Full Text] [Related]
2. Regional differences in the severity of Lewy body pathology across the olfactory cortex.
Silveira-Moriyama L; Holton JL; Kingsbury A; Ayling H; Petrie A; Sterlacci W; Poewe W; Maier H; Lees AJ; Revesz T
Neurosci Lett; 2009 Apr; 453(2):77-80. PubMed ID: 19356597
[TBL] [Abstract][Full Text] [Related]
3. Olfactory system pathology as a model of Lewy neurodegenerative disease.
Duda JE
J Neurol Sci; 2010 Feb; 289(1-2):49-54. PubMed ID: 19783257
[TBL] [Abstract][Full Text] [Related]
4. alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells.
Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Argandoña-Palacios L; Garcia-Muñozguren S; Martinez-Marcos A
Acta Neuropathol; 2010 Jun; 119(6):723-35. PubMed ID: 20383714
[TBL] [Abstract][Full Text] [Related]
5. Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.
Hall H; Reyes S; Landeck N; Bye C; Leanza G; Double K; Thompson L; Halliday G; Kirik D
Brain; 2014 Sep; 137(Pt 9):2493-508. PubMed ID: 25062696
[TBL] [Abstract][Full Text] [Related]
6. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.
Beach TG; White CL; Hladik CL; Sabbagh MN; Connor DJ; Shill HA; Sue LI; Sasse J; Bachalakuri J; Henry-Watson J; Akiyama H; Adler CH;
Acta Neuropathol; 2009 Feb; 117(2):169-74. PubMed ID: 18982334
[TBL] [Abstract][Full Text] [Related]
7. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.
Jellinger KA
Acta Neuropathol; 2009 Feb; 117(2):215-6; author reply 217-8. PubMed ID: 18985364
[No Abstract] [Full Text] [Related]
8. Can olfactory bulb biopsy be justified for the diagnosis of Parkinson's disease? Comments on "olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders".
Parkkinen L; Silveira-Moriyama L; Holton JL; Lees AJ; Revesz T
Acta Neuropathol; 2009 Feb; 117(2):213-4; author reply 217-8. PubMed ID: 19031077
[No Abstract] [Full Text] [Related]
9. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
10. Propagation of alpha-synuclein pathology from the olfactory bulb: possible role in the pathogenesis of dementia with Lewy bodies.
Cersosimo MG
Cell Tissue Res; 2018 Jul; 373(1):233-243. PubMed ID: 29196808
[TBL] [Abstract][Full Text] [Related]
11. The decrease of β-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies.
Beyer K; Domingo-Sàbat M; Santos C; Tolosa E; Ferrer I; Ariza A
Brain; 2010 Dec; 133(Pt 12):3724-33. PubMed ID: 20959308
[TBL] [Abstract][Full Text] [Related]
12. [Lewy bodies, a misleading marker for Parkinson's disease?].
Duyckaerts C; Hauw JJ
Bull Acad Natl Med; 2003; 187(2):277-92; discussion 292-3. PubMed ID: 14556441
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
14. NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC).
Yokota O; Terada S; Ishizu H; Tsuchiya K; Kitamura Y; Ikeda K; Uéda K; Kuroda S
Acta Neuropathol; 2002 Oct; 104(4):333-41. PubMed ID: 12200618
[TBL] [Abstract][Full Text] [Related]
15. Lewy bodies in the olfactory system and the hypothalamus.
Cersosimo MG; Benarroch EE; Raina GB
Handb Clin Neurol; 2021; 182():235-244. PubMed ID: 34266595
[TBL] [Abstract][Full Text] [Related]
16. The anterior olfactory nucleus in Parkinson's disease.
Pearce RK; Hawkes CH; Daniel SE
Mov Disord; 1995 May; 10(3):283-7. PubMed ID: 7651444
[TBL] [Abstract][Full Text] [Related]
17. How to diagnose dementia with Lewy bodies: state of the art.
Geser F; Wenning GK; Poewe W; McKeith I
Mov Disord; 2005 Aug; 20 Suppl 12():S11-20. PubMed ID: 16092075
[TBL] [Abstract][Full Text] [Related]
18. Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.
Junn E; Ronchetti RD; Quezado MM; Kim SY; Mouradian MM
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2047-52. PubMed ID: 12576551
[TBL] [Abstract][Full Text] [Related]
19. Intralaminar nuclei of the thalamus in Lewy body diseases.
Brooks D; Halliday GM
Brain Res Bull; 2009 Feb; 78(2-3):97-104. PubMed ID: 18804518
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias.
Parnetti L; Chiasserini D; Bellomo G; Giannandrea D; De Carlo C; Qureshi MM; Ardah MT; Varghese S; Bonanni L; Borroni B; Tambasco N; Eusebi P; Rossi A; Onofrj M; Padovani A; Calabresi P; El-Agnaf O
Mov Disord; 2011 Jul; 26(8):1428-35. PubMed ID: 21469206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]